Why is everyone talking about ResMed shares?

It's been a good year for ResMed shareholders. Let's find out why. Why is everyone talking about ResMed shares? You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services.

Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources , and more. Learn More ResMed Inc (ASX: RMD) shares are marching higher again on Monday. In late morning trade, shares in the S&P/ASX 200 Index (ASX: XJO) sleep disorder treatment company are changing hands for $37.



55 apiece, up 0.7%. ResMed shares ended last week on a strong note as well, gaining 1.

5% on Thursday and another 0.5% on Friday. This sees the ASX 200 healthcare stock up a very healthy 63% since this time last year.

And that's not including the 21.4 cents in unfranked dividends eligible shareholders will have received over the 12 months. And if you needed any more reasons to talk about ResMed shares, the company held its annual general meeting (AGM) on Thursday.

Here's what we learned. ResMed shares march higher during..

. Bernd Struben.